|
Generic Name : Alpha One-proteinase inhibitor
Pronunciation : AL-fa 1 PROE-teen-ase
Trade Name(s):
International- Zemaira. This medication is an alpha-1 protease inhibitor, prescribed for emphysema. When it is not to be taken (Contraindications):
When it is to be taken : IV- The recommended dose is 60-mg/kg body weight administered once weekly. How it should be taken : It comes as a solution for injection to be administered by a healthcare provider into the vein. Special Instruction : * Caution should be exercised in patients with history of heart or circulatory problems, any allergy, who are taking other medications, children, during pregnancy and breastfeeding. * It may cause dizziness, do not drive a car or operate machinery while taking this medication. Side Effects : Most Common - Weakness, injection site pain, dizziness, headache, tingling, and itching. Miscellaneous - Upper respiratory tract infection, inflammation sinus, injection site bleeding, sore throat, fever, runny nose, asthma, chest pain, increased cough, rash, and infection. * Avoid excess dosage. Storage Conditions : Store it in room temperature (25°C). |
![]() Comment & Contribute
![]()
![]() ![]() | ||


